17
Participants
Start Date
November 30, 2007
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
Xifaxan
Open-Label Treatment at 400 mg by mouth, 3 times a day, for 7 days; only for those symptomatic and positive SBBO patients.
SmartPill
The SmartPill is a single-use, ingestible capsule that utilizes sensor technology to measure pressure, pH and temperature throughout the entire GI tract. The ACT-1 (SmartPill) GI Monitoring System includes an ingestible capsule, a receiver and video display software.
Lactulose hydrogen breath test (H_2BT)
A hydrogen breath test provides information about the digestion of certain sugars or carbohydrates, such as milk sugar (lactose) or fruit sugar (fructose). The test is also used for detecting abnormal growth of bacteria within the small bowel by having the patient ingest lactulose.
Mayo Clinic Arizona, Scottsdale
Lead Sponsor
The SmartPill Corporation
INDUSTRY
Mayo Clinic
OTHER